more_reports

Esperion Therapeutics Inc.

ESPR:NASDAQ

Esperion is the Lipid Management Company committed to developing and commercializing convenient, complementary, cost-effective, once-daily, oral therapies for the treatment of patients with elevated LDL-C.

streetwise book logo Streetwise Company Fact Sheet

2025/4/10 5:02:22

(ESPR:NASDAQ)

Analyst coverage

Needham & Co — Serge Belanger
JMP Securities — Jason Butler
Jefferies & Co. — Dennis Ding
J.P. Morgan — Jessica Fye
H.C. Wainwright & Co. — Dr. Joseph Pantginis
BTIG Research — Dr. Thomas Shrader
Bank of America Securities — Dr. Jason Zemansky

Streetwise Reports Articles

12/03/2024 - View Article